Page Metadata

Scythian Biosciences

Company Profile

Scythian Biosciences Inc. is a pre-clinical research and development company that is in the process of developing drug therapies. The first project underway is the development of a proprietary cannabinoid-based combination drug therapy for the treatment of concussions and traumatic brain injury. 

In addition to this primary line of research and development, Scythian also intends to develop other potential cannabinoid and non-cannabinoid based pharmaceutical products, including one that is in development for treatment of gastro-inflammatory disease.

Summary

--
--
--
-- - --
--
--
--
--
--
--
--
--

Scythian Biosciences

Executive Team
Rob Reid – CEO, Chairman, and Director
Maghsoud Dariani – Chief Science Officer
Arvin Ramos - Chief Financial Officer
David Schrader – Chief Operating Officer
Company IR Website
Nasdaq International, February 22, 2018

Company Details

WEBSITE
REGISTERED OFFICE ADDRESS
HEAD OFFICE TELEPHONE
GICS INDUSTRY GROUP

Resources


Social Media


Photo Gallery

Scythian Biosciences Corp

Scythian Logo for Rght Rail
Learn about the company Learn more about Scythian Biosciences' products and services

Scroll up